Smith M D MD - OmicsDI

Show results for

Unknown (2863)
Genomics (41)
Metabolomics (41)
Transcriptomics (21)
Proteomics (21)
Genomic (4)

Organisms

Homo sapiens (62)
Mus musculus (14)
Yersinia pestis (2)
Escherichia coli (1)
Rattus norvegicus (1)
Severe acute respiratory syndrome coronavirus 2 (1)

Repository

MetaboLights (41)
EGA (37)
biostudies-arrayexpress (25)
pride (17)
dbGaP (4)
MassIVE (2)
PanoramaPublic (1)
PAXDB (1)

Tissue

Cell culture (5)
Blood (2)
Brain (2)
Epithelial cell (2)
Blood plasma (1)
Iris (1)
Kidney (1)
Lung epithelium (1)
Monocyte (1)
Permanent cell line cell (1)
Plasma cell (1)
Primary cell line cell (1)
Sclera (1)
T cell (1)

Disease

Acute leukemia (1)
Brain cancer (1)
COVID-19 (1)
Colon cancer (1)
Coronavirus infectious disease (1)
Diffuse midline glioma (1)
Disease free (1)
Lung adenocarcinoma (1)
Multiple myeloma (1)
Neurodevelopmental delay (1)
Pancreatic ductal adenocarcinoma (1)

Technology Type

Mass spectrometry (35)
Mass Spectrometry (17)
Shotgun proteomics (9)
Illumina 15K (8)
Mass spectrometry assay (6)
Bottom-up proteomics (4)
Affinity purification coupled with mass spectrometry proteomics (3)
NMR spectroscopy (2)
Data-dependent acquisition (2)
Gel-based experiment (2)
Illumina HiSeq 2500 (1)
Affinity proteomics (1)
Data-independent acquisition (1)
DiaPASEF (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (14)
Liquid Chromatography MS - negative - reverse phase (10)
Liquid Chromatography MS - negative - hilic (7)
Liquid Chromatography MS - positive - hilic (6)
Liquid Chromatography MS - Negative (LC-MS (Negative)) (3)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (3)
Liquid Chromatography MS - (2)
Liquid Chromatography MS - alternating - reverse-phase (2)
TOF Pegasus HT (LECO) (2)
GenePix 4000A [Axon Instruments] (1)
Illumina HiSeq 2000 (1)
Illumina HiSeq 4000 (1)
Orbitrap Exploris 480 (1)
Synapt MS (1)
6490 Triple Quadrupole LC/MS (Agilent) (1)
6540 Q-TOF LC/MS (Agilent) (1)
Bruker (1)
Direct infusion MS - negative (1)
Direct infusion MS - positive (1)
Exactive (Thermo Scientific) (1)
Gas Chromatography MS - (1)
Gas Chromatography MS - Positive (GC-MS (Positive)) (1)
Gas Chromatography MS - positive (1)
LTQ XL (Thermo Scientific) (1)
Liquid Chromatography MS - Alternating (LC-MS (Alternating)) (1)
Liquid Chromatography MS - NEG - reverse phase (1)
Liquid Chromatography MS - POS - reverse phase (1)
Liquid Chromatography MS - alternating - hilic (1)
Liquid Chromatography MS - negative - reverse-phase (1)
Liquid Chromatography MS - positive - reverse-phase (1)

Publication Date

2022 (10)
2021 (9)
2026 (7)
2025 (7)
2024 (6)
2014 (6)
2023 (6)
2020 (6)
2013 (5)
2011 (4)
2019 (4)
2010 (3)
2017 (3)
2018 (3)
2016 (2)
2006 (2)
2012 (1)
2008 (1)
2007 (1)
2015 (1)

UNIPROT ID/AC

283166.BH03420 (1)
283166.BH06860 (1)
283166.BH06890 (1)
283166.BH09080 (1)
283166.BH09420 (1)
283166.BH09470 (1)
283166.BH09490 (1)
283166.BH10530 (1)
283166.BH10720 (1)
283166.BH13650 (1)
283166.BH13700 (1)
A0A0G2Q8I8_BARHE (1)
A0A0G2Q8J4_BARHE (1)
A0A0G2Q8J9_BARHE (1)
A0A0G2Q8K2_BARHE (1)
A0A0G2Q8K8_BARHE (1)
A0A0G2Q8K9_BARHE (1)
A0A0G2Q8L7_BARHE (1)
A0A0G2Q8L8_BARHE (1)
A0A0G2Q8M3_BARHE (1)
A0A0H3LV82_BARHE (1)
A0A0H3LV87_BARHE (1)
A0A0H3LV91_BARHE (1)
A0A0H3LV96_BARHE (1)
A0A0H3LV99_BARHE (1)
A0A0H3LVA4_BARHE (1)
A0A0H3LVB7_BARHE (1)
A0A0H3LVC1_BARHE (1)
A0A0H3LVC5_BARHE (1)
A0A0H3LVC8_BARHE (1)

CHEBI ID

CHEBI:15891 (13)
CHEBI:16704 (10)
CHEBI:17368 (10)
CHEBI:15741 (9)
CHEBI:16737 (9)
CHEBI:18211 (9)
CHEBI:30915 (9)
CHEBI:7916 (9)
CHEBI:16196 (8)
CHEBI:17568 (8)
CHEBI:17775 (8)
CHEBI:27897 (8)
CHEBI:28044 (8)
CHEBI:28842 (8)
CHEBI:15354 (7)
CHEBI:15756 (7)
CHEBI:16015 (7)
CHEBI:16235 (7)
CHEBI:16750 (7)
CHEBI:16811 (7)
CHEBI:16828 (7)
CHEBI:16856 (7)
CHEBI:16919 (7)
CHEBI:17053 (7)
CHEBI:17596 (7)
CHEBI:18012 (7)
CHEBI:18186 (7)
CHEBI:18237 (7)
CHEBI:18257 (7)
CHEBI:25017 (7)

Metabolite Name

Inosine (7)
Taurine (7)
Adenine (6)
Creatinine (6)
Adenosine (5)
Choline (5)
Creatine (5)
Hypoxanthine (5)
Isoleucine (5)
L-Glutamic acid (5)
L-Glutamine (5)
Palmitic acid (5)
Succinic acid (5)
Uric acid (5)
12-Hydroxydodecanoic acid (4)
16-Hydroxyhexadecanoic acid (4)
3-Hydroxybutyric acid (4)
Azelaic acid (4)
Citrulline (4)
Cytosine (4)
Deoxycholic acid (4)
Docosahexaenoic acid (4)
Gluconic acid (4)
Guanine (4)
Guanosine (4)
L-Arginine (4)
L-Histidine (4)
L-Leucine (4)
L-Tyrosine (4)
Oleic acid (4)

Study type

Transcription profiling by array (13)
Methylation profiling by high throughput sequencing (3)
Unknown experiment type (2)
RNA-seq of coding RNA (2)
MeDIP-seq (1)
Cell line - One-color microarray (1)
Comparative genomic hybridization by array (1)
Other (1)
ChIP-seq (1)

Release Date

2021 (292)
2022 (275)
2023 (271)
2024 (237)
2025 (212)
2020 (208)
2019 (202)
2018 (192)
2015 (149)
2014 (145)
2016 (130)
2017 (127)
2013 (96)
2011 (89)
2012 (87)
2010 (55)
2009 (41)
2026 (32)
2008 (24)
2006 (6)
2005 (6)
2007 (5)
2004 (3)
2003 (1)
2001 (1)
2000 (1)
1999 (1)

Lab affiliation

Wilmer Eye Institute, Smith Building, M015, 400 N. Broadway, Baltimore, MD 21287 (2)
1. Cancer Signalling Research Group, School of Biomedical Sciences and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, AUSTRALIA 2. Precision Medicine Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, AUSTRALIA 3. Paediatric Program, Mark Hughes Foundation Centre for Brain Cancer Research, College of Health, Medicine, and Wellbeing, Callaghan, NSW, AUSTRALIA (1)
95 Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III - Paul Sabatier (UT3), Toulouse, 31077, France (1)
Department of Biochemistry and Chemistry, Research Centre for Extracellular Vesicles, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC 3086, Australia (1)
Department of Biochemistry and Molecular Biology, University of Calgary, Alberta, Canada; Department of Physiology and Pharmacology, University of Calgary, Alberta, Canada; The Hotchkiss Brain Institute, University of Calgary, Alberta, Canada; McCaig Institute for Bone and Joint Health, University of Calgary, Alberta, Canada (1)
Department of Cellular and Molecular Pharmacology University of California San Francisco (UCSF) San Francisco, CA 94158 USA (1)
Department of Pediatrics Indiana University School of Medicine Riley Hospital for Children (1)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD/NIH) Section on Cell Cycle Regulation Building 49, Room 5A30 49 Convent Drive Bethesda, MD 20892-4480 (1)
Lineberger Comprehensive Cancer Center Department of Pharmacology UNC Chapel Hill Chapel Hill NC USA (1)
Moffitt Cancer Center Tampa, FL, USA (1)
National Cancer Institute National Institutes of Health Bethesda, MD United States (1)
Neurosurgeon & Senior Scientist Developmental and Stem Cell Biology, The Hospital for Sick Children, Canada (1)
Reader | Centre for Genomics and Computational Biology Barts Cancer Institute Queen Mary, University of London John Vane Science Centre, Charterhouse Square, London EC1M 6BQ Tel: +44 (0)20 7882 8266 (1)
School of Biosciences University of Sheffield United Kingdom (1)
Section Mass Spectrometry and Proteomics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (1)
Wilmer Eye Institute, Smith Building, M015, 400 N Broadway, Baltimore, MD 21287 (1)

Previous page
1 / 300
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 300
Next page

Sort by:

Relevance

Page size

Vitamin D levels in Smith-Lemli-Opitz syndrome.

Not available

S-EPMC5603413 | biostudies-literature

Array results for differential gene expression in 661W, a mouse cone photoreceptor-derived cell line, comparing cells incubated with vehicle controls vs. those treated with either of two 7-dehdyrocholesterol-derived oxysterols or cholesterol

RELEVANCE: Smith-Lemli-Opitz syndrome (SLOS) is a human disease caused by mutations in the gene coding for the enzyme DHCR7 (7-dehydrocholesterol (7DHC) reductase), which catalyzes the final step of cholesterol biosynthesis. Accumulated 7DHC in tissues and body fluids of SLOS patients gives rise t...

ORGANISM(S): Mus musculus

2021-03-20 | E-MTAB-10055 | biostudies-arrayexpress

Development, behaviour and sensory processing in Marshall-Smith syndrome and Malan syndrome: phenotype comparison in two related syndromes.

Not available

S-EPMC8957705 | biostudies-literature

Untargeted metabolomics profiling reveals exercise intensity-dependent alterations in Thoroughbred racehorses’ plasma after routine conditioning sessions

Thoroughbred (TB) racehorses are subjected to rigorous conditioning programs involving exercise sessions of various types, distances and intensities. These programs aim to optimize both their physical and mental capabilities, which are essential to achieve maximal performance. Conventional invest...

2024-01-16 | MTBLS8285 | MetaboLights

Membrane Stabilization of Helical Previtamin D Conformers as Possible Enhancement of Vitamin D Photoproduction.

Not available

S-EPMC11421079 | biostudies-literature

Transcriptional analysis of luxS-null strain in Yersinia pestis CO92 at 37M-BM-0C

Yersinia pestis, the etiological agent of plague, is able to sense cell density by quorum sensing. The function of quorum sensing in Y. pestis is not clear. Here, the process of autoinducer 2 (AI-2) quorum sensing was investigated by comparing transcript profiles when luxS gene was knocked out. The ...

ORGANISM(S): Yersinia pestis

2013-09-05 | E-GEOD-22849 | biostudies-arrayexpress

Surgeon influence on use of needle biopsy in patients with breast cancer: a national medicare study.

Not available

S-EPMC4164811 | biostudies-literature

Progression of diabetic nephropathy and vitamin D serum levels: A pooled analysis of 7722 patients.

Not available

S-EPMC10638614 | biostudies-literature

No prognostic value added by vitamin D pathway SNPs to current prognostic system for melanoma survival.

Not available

S-EPMC5360355 | biostudies-literature

Human mesenchymal stromal cell-derived extracellular vesicles attenuate aortic aneurysm formation and macrophage activation via microRNA-147.